Get started
Aarti Pharmalabs LimitedAarti Pharmalabs LimitedAarti Pharmalabs Limited

Aarti Pharmalabs Limited

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Seasonals

AARTIPHARM trade ideas

AARTI PHARMALABS – Retest at Breakout Zone📈 AARTI PHARMALABS – Retest at Breakout Zone Date: June 23, 2025 | Exchange: NSE | Timeframe: Daily Aarti Pharmalabs is retesting its previous breakout zone near 835–840 after a strong rally. Price is showing early signs of demand from this support area. Key Levels: * Support: 838 / 820 * Resistance: 917 * MACD: Bearish crossover but flattening * RSI: Holding above 50, indicating strength View: Bullish bias if price holds above 835. Rebound from this demand zone could lead to a retest of recent highs & even head to all time high
NSE:AARTIPHARMLong
by krunal_patadia95
BUY TODAY SELL TOMORROW for 5%DON’T HAVE TIME TO MANAGE YOUR TRADES? - Take BTST trades at 3:25 pm every day - Try to exit by taking 4-7% profit of each trade - SL can also be maintained as closing below the low of the breakout candle Now, why do I prefer BTST over swing trades? The primary reason is that I have observed that 90% of the stocks give most of the movement in just 1-2 days and the rest of the time they either consolidate or fall Trendline Breakout in AARTIPHARM BUY TODAY SELL TOMORROW for 5%
NSE:AARTIPHARM
by Kapil-Mittal
2
Aarti Pharmalabs | Rectangle Pattern Breakout | Big Upside AheadHello everyone! I hope you all are doing great. 😊 Today, I’ve got something interesting for you – a solid breakout in Aarti Pharmalabs! After months of going sideways, Aarti Pharmalabs has finally woken up! The stock was stuck between 555 (support) and 695 (resistance) for a long time, but now, the bulls have taken control and pushed it past this critical resistance zone. Here’s what’s happening: The price tested 695 multiple times but kept getting rejected. This time, it broke out with strong volume , showing that buyers mean business. This could be the beginning of a strong uptrend! Key Levels to Watch: 🔹 Short-Term Target: 815 🔹 Final Target: 895 🔹 Best Entry Zone: 750-715 (if we get a pullback, it’s a golden chance!) 🔹 Stop Loss: 670 (always manage risk!) Fundamental View: Aarti Pharmalabs is growing steadily, expanding into regulated markets , and benefiting from increasing demand for specialty chemicals . The sector looks strong, but risks like raw material costs and regulatory challenges remain. Despite that, the stock is still at a reasonable valuation and has room for further upside. What’s Next? As long as the breakout holds above 695 , the bullish momentum should continue. If we see a retest of the breakout zone, it could be a great entry point before the next rally. What do you think? Will Aarti Pharmalabs hit 895 soon? Drop your thoughts in the comments! Disclaimer: This analysis is for educational purposes only . Please trade responsibly and consult a financial advisor before making any decisions. If you found this analysis helpful, don’t forget to like, follow, and share your thoughts in the comments below! Your support keeps me motivated to share more insights. Let’s grow and learn together— happy trading!
NSE:AARTIPHARMLong
by TraderRahulPal
Aarti Pharmalabs Ltd.: Breakout or Fakeout?Aarti Pharmalabs Ltd. is a prominent player in the pharmaceutical industry, specializing in the manufacturing of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and xanthine derivatives. The company operates six manufacturing plants and two R&D centers, catering to a diverse range of therapeutic areas, including cardiovascular, anti-asthmatic, anti-cancer, and anti-diabetic segments. Recent Stock Performance As of February 12, 2025, Aarti Pharmalabs' stock closed at ₹741.20 on the NSE, marking a 3.26% increase from its previous close of ₹717.85. Over the past year, the stock has demonstrated significant growth, achieving a 52-week high of ₹771.00 and a low of ₹399.55. Financial Highlights In the quarter ending December 31, 2024, the company reported a consolidated total income of ₹542.81 crore, reflecting a 17.36% increase from the previous quarter and a 20.60% rise compared to the same quarter the previous year. The net profit after tax for this period stood at ₹73.99 crore. Key financial metrics include: Price-to-Earnings (P/E) Ratio: 26.94 Earnings Per Share (EPS): ₹27.51 Price-to-Book (P/B) Ratio: 3.70 Market Capitalization: ₹6,635.64 crore Dividend Announcement On February 5, 2025, Aarti Pharmalabs declared an interim dividend of ₹2.5 per share, with a record date set for February 14, 2025. Operational Developments In January 2025, the Gujarat Pollution Control Board directed the company to temporarily close its Vapi plant due to environmental concerns. The company has since taken measures to address these issues and has resumed operations at the facility. Fundamental and Financial Ratios Profitability Ratios: Return on Equity (ROE): 12.98% (indicating efficient utilization of shareholder equity to generate profits) Return on Assets (ROA): 7.97% (showing effective management of assets in generating earnings) Valuation Ratios: Sector P/E Ratio: 30.50 (providing a benchmark for comparison with the company's P/E ratio) Price-to-Earnings (P/E) Ratio: 24.73 (reflecting investor expectations of future earnings growth) Price-to-Book (P/B) Ratio: 3.32 (indicating market confidence in asset management) Technical Analysis From 23rd July 2024 to 6th February 2025, the price was in a consolidation phase between ₹551.05 to ₹721.70, forming a rectangle channel pattern. On 7th February 2025, the stock broke out of this rectangle channel. If the weekly closing price remains above ₹762, we can expect momentum toward the Resistance ₹871, ₹931, and ₹997. However, if the price declines after the weekly close of ₹762, we can expect a reversal in the bottom zone at ₹627 to ₹658 level. Conclusion Aarti Pharmalabs Ltd. continues to exhibit robust financial performance and strategic growth initiatives. Investors are advised to monitor the company's operational developments and market conditions to make informed decisions.
NSE:AARTIPHARM
by ALICEBLUE
1
Amazing breakout on WEEKLY Timeframe - AARTIPHARMCheckout an amazing breakout happened in the stock in Weekly timeframe, macroscopically seen in Daily timeframe. Having a great favor that the stock might be bullish expecting a staggering returns of minimum 25% TGT. IMPORTANT BREAKOUT LEVELS ARE ALWAYS RESPECTED! NOTE for learners: Place the breakout levels as per the chart shared and track it yourself to get amazed!! #No complicated chart patterns #No big big indicators #No Excel sheet or number magics TRADE IDEA: WAIT FOR THE STOCK TO BREAKOUT IN WEEKLY TIMEFRAME ABOVE THIS LEVEL. Checkout an amazing breakout happened in the stock in Weekly timeframe. Breakouts happening in longer timeframe is way more powerful than the breakouts seen in Daily timeframe. You can blindly invest once the weekly candle closes above the breakout line and stay invested forever. Also these stocks breakouts are lifelong predictions, it means technically these breakouts happen giving more returns in the longer runs. Hence, even when the scrip makes a loss of 10% / 20% / 30% / 50%, the stock will regain and turn around. Once they again enter the same breakout level, they will flyyyyyyyyyyyy like a ROCKET if held in the portfolio in the longer run. Time makes money, GREEDY & EGO will not make money. Also, magically these breakouts tend to prove that the companies turn around and fundamentally becoming strong. Also the magic happens when more diversification is done in various sectors under various scripts with equal money invested in each N500 scripts. The real deal is when to purchase and where to purchase the stock. That is where Breakout study comes into play. LET'S PUMP IN SOME MONEY AND REVOLUTIONIZE THE NATION'S ECONOMY!
NSE:AARTIPHARMLong
by Yoyohoneysingh93
AARTI PHARMA- Strong Breakout from Ascending Channel ✅ The stock is trading within an ascending channel, with the price nearing the upper trendline, indicating a potential breakout. The stock is attempting to break above this trendline, which could lead to a significant bullish move. ✅ The RSI is trending upwards and is currently around the 70 mark, suggesting strong bullish momentum. The recent surge in volume supports the possibility of a breakout. ✅ A successful breakout above the upper trendline, combined with sustained volume, could propel the stock towards higher levels, potentially targeting ₹750. Traders should monitor for a close above the trendline to confirm the breakout.
NSE:AARTIPHARMLong
by Marketik
AARTIPHARM bullish; above 659 ? - Monday 5th Aug.AARTIPHARM: Bullish if ~6-week long resistance @653 is broken on good volumes and sustains. The above information does not constitute investment/trading recommendation and it is purely for educational purpose.... INTRADAY Trading Strategy in 3 stages of breakouts: 1) Impulse upmove stage: The strong upmove (nearly upto 1.5% from trigger-price) happens within five minutes. "High Risk Traders" buy on breakouts in hope of continuation of upmove. "High Risk Traders" may have to patiently wait through the Pullback-Consolidation stage to realize profits. High risk:High reward set up as breakouts may fakeout (reversal)also 2) Pullback-Consolidation stage: After the above "Impulse upmove stage"; the price may then pull back and move sideways (between "Open" price and "High" of the above "Impulse upmove stage"). "Safe traders" with minimum risk profile wait for a breakout from the consolidation stage to enter into trade , to book high profits in the final "Breakout continuation" stage 3) Breakout continuation: Stocks often in the third stage breaks up above the "High" of the first "Impulse upmove stage" and continue to go higher again.(another 2-3%) Both Safe Traders/High Risk Traders book profits at this stage SWING Trading Strategy: Position is kept open, only upon stock closing above the entry price on day closing basis and is held on for 5-10 trading sessions for larger gains (5-10%) The above information do not constitute, financial, investment, trading, or other types of advice or recommendation. It is purely for educational purpose....
NSE:AARTIPHARMLong
by JJ_Breakouts
BUY TODAY SELL TOMORROW for 5%DON’T HAVE TIME TO MANAGE YOUR TRADES? - Take BTST trades at 3:25 pm every day - Try to exit by taking 4-7% profit of each trade - SL can also be maintained as closing below the low of the breakout candle Now, why do I prefer BTST over swing trades? The primary reason is that I have observed that 90% of the stocks give most of the movement in just 1-2 days and the rest of the time they either consolidate or fall. RESISTANCE Breakout in AARTIPHARMA BUY TODAY SELL TOMORROW for 5%
NSE:AARTIPHARMLong
by Kapil-Mittal
3